Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21844910 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome

Indicates status has not been verified in more than two years